These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 28645312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL.
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [Abstract] [Full Text] [Related]

  • 5. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei Y, Tang K, Sun Y, Zhang W, Li S, He Q, Zhou J, Chen Y, Luo J, Jiang W, Ke Z.
    Theranostics; 2020 Mar; 10(6):2553-2570. PubMed ID: 32194819
    [Abstract] [Full Text] [Related]

  • 6. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
    Wang D, Lu G, Shao Y, Xu D.
    Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
    [Abstract] [Full Text] [Related]

  • 7. [Mechanism of HOXC6 promoting the progression of prostate cancer by activating the SFRP1/Wnt/β-catenin signaling pathway].
    Zheng YJ, Li WM, Zheng LC, Zhou YF, Wang J, Xia WM, Ye WJ, Yu JS.
    Zhonghua Nan Ke Xue; 2024 Jul; 30(7):579-587. PubMed ID: 39212391
    [Abstract] [Full Text] [Related]

  • 8. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W, Wang D, Li C, Shu T, Zhang W, Fu X.
    Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
    [Abstract] [Full Text] [Related]

  • 9. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.
    Zhang Q, Huang H, Liu A, Li J, Liu C, Sun B, Chen L, Gao Y, Xu D, Su C.
    EBioMedicine; 2019 Apr; 42():397-407. PubMed ID: 30904606
    [Abstract] [Full Text] [Related]

  • 10. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, Wang Y, Xue Y, Yang J, Tan Q, Wang Z, Song X.
    Oncotarget; 2015 May 10; 6(13):10964-77. PubMed ID: 25844602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
    Zhou W, Li Y, Gou S, Xiong J, Wu H, Wang C, Yan H, Liu T.
    Oncotarget; 2015 Nov 10; 6(35):37557-69. PubMed ID: 26485754
    [Abstract] [Full Text] [Related]

  • 13. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
    Shen H, Yan W, Yuan J, Wang Z, Wang C.
    J Exp Clin Cancer Res; 2019 Jun 07; 38(1):243. PubMed ID: 31174562
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.
    Am J Chin Med; 2018 Jun 07; 46(4):891-910. PubMed ID: 29792038
    [Abstract] [Full Text] [Related]

  • 15. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway.
    Gao Y, Cai A, Xi H, Li J, Xu W, Zhang Y, Zhang K, Cui J, Wu X, Wei B, Chen L.
    Stem Cell Res Ther; 2017 Apr 26; 8(1):98. PubMed ID: 28446252
    [Abstract] [Full Text] [Related]

  • 16. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M, Walther N, Diederichs C, Schill F, Monecke S, Salinas G, Sturm D, Pfister SM, Dressel R, Johnsen SA, Kramm CM.
    Oncotarget; 2017 Apr 18; 8(16):27300-27313. PubMed ID: 28460484
    [Abstract] [Full Text] [Related]

  • 17. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
    Fu Q, Gao Y, Yang F, Mao T, Sun Z, Wang H, Song B, Li X.
    Biomed Pharmacother; 2018 Jan 18; 97():120-127. PubMed ID: 29080452
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z, Zheng H, Liu X, Zhang W, Zhu J, Wu G, Cao L, Song J, Wu S, Song L, Li J.
    Oncotarget; 2016 Apr 26; 7(17):24076-87. PubMed ID: 26992223
    [Abstract] [Full Text] [Related]

  • 19. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
    Song XL, Huang B, Zhou BW, Wang C, Liao ZW, Yu Y, Zhao SC.
    Biomed Pharmacother; 2018 Mar 26; 99():369-374. PubMed ID: 29358129
    [Abstract] [Full Text] [Related]

  • 20. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY, Zhou GQ, Jiang W, Sun Y, Xu YF, Li YQ, Tang XR, Wen X, He QM, Yang XJ, Liu N, Ma J.
    Cancer Prev Res (Phila); 2015 Oct 26; 8(10):968-77. PubMed ID: 26276746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.